A randomized controlled trial of adjunctive speleotherapy in asthma, COPD and long COVID
Joachim Schwarz, Madelaine Eicke, Nina Schwedler, Gerrit von Komorowski, Verena Goldfuss, Wolfgang Fladerer, Béatrice Barbolan, Martin Mogk, Natascha Sommer · 2026
Read A randomized controlled trial of adjunctive speleotherapy in asthma, COPD and long COVID by Joachim Schwarz, Madelaine Eicke, Nina Schwedler, Gerrit von Komorowski, Verena Goldfuss, Wolfgang Fladerer, Béatrice Barbolan, Martin Mogk, Natascha Sommer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13197469.txt.
Description
Joachim Schwarz and eight co-authors run a randomized trial of cave climate therapy for chronic lung diseases, in this 2026 paper. Speleotherapy rests patients in underground spaces with cool, clean, humid air. It is an established add-on in parts of Europe, but controlled evidence is thin.
Two hundred eight patients with asthma, COPD, or long COVID across nine centers in three countries received either a three-week course, six two-hour sessions, alongside standard care, or standard care alone. In asthma, the main lab endpoint, airway inflammation, did not improve, yet patients reported clearly better control and quality of life, with modest lung function gains. COPD patients reported less symptom burden. Long COVID patients breathed easier and reported less breathlessness persisting to three months. Breathing muscle strength improved across the full intervention group. The authors present patient-reported gains as the therapy's real signal.
Catalog record
| CREATOR | Joachim Schwarz, Madelaine Eicke, Nina Schwedler, Gerrit von Komorowski, Verena Goldfuss, Wolfgang Fladerer, Béatrice Barbolan, Martin Mogk, Natascha Sommer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |